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Ob alias. This study was designed to compare freedom from
combined cardiac events (death, mtginn, myocardial Infarction) at
I•, 3• said S•year follow-up in patients with multivessel disease
randomized to either percutaneous transiwninal coronary anglo-
o" coronary artery bypass paft surgery.
Ba s gmwad. Pe+cutaneone transluminal coronary angioplasty
has beer an effective approach in patients with coronary artery
disease, bent its role In patients with multivesel coronary artery
lease Is will controversial .
Aloha.(Are-hundred twenty-seven patients with multivessel
disease ad lesions suitable for either form of therapy were
randomized to either coronary artery bypass grafting (a = 64) or
coronary ugloplasty (n ae 63) . In this study we report the
Immediate results and freedom from combined cardiac events at
1-year fellow-up.
Raedra. Demographic, clinical and anglographic chars rerls-
tics were dollar In both group. There were no differences in
In-hospital deaths, frequency of periprocodure myocardial infarc-
Percutaneous transluminal coronary angioplasty has been
shown to be an effective therapeutic approach in patients
with coronary artery disease (1,2). Its role in patients with
single-vessel coronary artery disease has been well estab-
lished (1,2).
Coronary angioplasty has been used with increasing
frequency in the treatment of patients with multivessel
coronary artery disease (3-6) . Although its success rate is
high and the
incidence of major complications is low, the
efficacy of coronary angioplasty in the treatment of patients
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Lion or need for emergency revaseuiarlzation procedures between
the two groups. At 1-year follow-up, there were no differences In
mortality or In the Incidence of myocardial infarction between the
groups. However, patients treated with coronary artery bypass
grafting were more frequently free of angina, reinterventlons and
combined cardiac events than were patients treated with coronary
angioplasty (83.5% vs. 63.7%, p < 0.005) . In-hospital cost and
cumulative cost at 1-year follow-up were greater for the coronary
artery bypass grafting than for the coronary angioplasty group .
Conclusions. No significant differences were found in major
In-hospital complications between patients treated with coronary
artery bypass grafting or coronary angioplasty . Although at
1-year follow-up there were no differences In survival and freedom
from myocardial infarction, patients in the coronary artery by-
pass grafting
group were more frequently free from angina,
reinterventlens and combined events than were patients In the
coronary angioplasty group.
(J Am Coil Cordial 1993 ;22.16M6-7)
with multivessel coronary artery disease remains controver-
sial (7,8) . Specifically, questions regarding safety, indica-
dons, patient selection and long-term follow-up remain un-
answered. On the other hand, coronary artery bypass graft
surgery has been shown to be an effective technique in
ameliorating symptoms by improving functional capacity,
prolonging survival, and decreasing cardiac events at fol-
low-up in symptomatic patients with significant triple vessel
coronary artery disease unresponsive to medical therapy
(9,10).
There are patients with coronary artery disease in whom
coronary angioplasty is a reasonable first therapeutic choice ;
there are other patients in whom coronary artery bypass
surgery is a better option . However, there are patients in
whom either approach may be chosen and consequently, the
choice of a revascularization approach remains open to
question. Therefore, the present study, Argentine Random-
ized Trial of Percutaneous Transluminal Coronary Angio-
plasty Versus Coronary Artery Bypass Surgery in Multives-
sel Disease (ERACI) was undertaken to compare the role of
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Figure 1 . Flow diagram of the patient study group. CABG =
coronary artery bypass graft surgery ; PTCA = coronary angio
.
plasty; pts = patients
.
coronary angioplasty versus coronary artery bypass surgery
in the treatment of this latter group of patients with multi-
vessel disease in whom the revascularization approach re-
mains open to question and in whom the lesions being
considered in the revascularization strategy were amenable
to both coronary angioplasty and coronary artery bypass
surgery. In this initial communication we report the imme-
diate and the 1st year follow-up results of this randomized
trial .
Methods
Study patients. From a total of 1,409 patients with a
presumptive clinical diagnosis of coronary artery disease
who underwent coronary arteriography at the Anchorena
Hospital between June of 1988 and December of 1990, 748
patients had an indication for revascularization
. There was
no need for revascularization in the other 661 patients
because of the presence of normal coronary arteries, non-
significant coronary artery disease or coronary disease ame-
nable to medical therapy (Fig . 1) .
From the 748 patients who required myocardial revascu-
larization, 302 met the entrance criteria for randomization
and 446 did not . In this latter group coronary angioplasty
was performed in 309 patients and coronary artery bypass
surgery in 137 (Fig. 1), Coronary angioplasty was performed
in these 309 patients because of the following reasons :
1) presence of single-vessel coronary artery disease (72%),
2) two-vessel disease without significant involvement of the
proximal left anterior descending coronary artery (9%),
3) prior history of coronary artery bypass surgery (10 .9%),
4) evolving acute myocardial infarction or acute myocardial
infarction associated with severe left ventricular dysfunction
(7%), and 5) associated significant valvular heart disease
(0.6%). Coronary artery bypass surgery was performed in
the other 137 patients for one of the following reasons :
1) presence of severe triple-vessel disease with depressed
left ventricular ejection fraction, 2) multivessel coronary
artery disease with poor distal vessels and diffuse disease,
and 3) significant main left stenosis . This group also included
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five patients with single-vessel proximal left anterior de-
scending coronary artery disease whose primary physician
had a preference for a left internal mammary artery graft to
the left anterior descending coronary artery .
From the 302 patients who met the entrance criteria for
randomization, 127 were randomized (63 to coronary angio-
plasty and 64 to coronary artery bypass surgery) and 175
were not . From these latter 175 patients with randomizable
criteria who were not randomized, 99 patients were treated
with angioplasty and 76 patients with bypass grafting
(Fig . 1) .
In the randomized group, there were 108 men and 19
women with a mean age of 58 ± 5 (33 to 76) years . Both
revascularization procedures (coronary angioplasty and cor-
onary artery bypass surgery) were performed att the An-
chorena Hospital in Buenos Aires, Argentina.
The study. Only patients with multivessel coronary ar-
tery disease with clinical indication for myocardial revascu-
larization but in whom the choice of revascularization ap-
proach was open to question were included in this study . In
these patients complete functional revascularization could
be achieved by the treatment of multivessel coronary lesions
amenable to either coronary angioplasty or coronary artery
bypass surgery .
Patients signed a consent form reviewed and approved by
the Committee of Human Studies of the Anchorena Hospi-
tal .
Aims of the study. The primary aim of the study was to
compare freedom from combined coronary cardiac events
(death, myocardial infarction, repeat revascularization pro-
cedures and angina) at 1-, 3- and 5-year follow-up between
patients who underwent coronary artery bypass grafting or
coronary angioplasty .
Secondary aims were I) to compare major in-hospital
complications (death, Q wave myocardial infarction and
need for emergency revascularization procedures) between
both revascularization modalities ; 2) to compare complete-
ness of revascularization achieved by both procedures ; and
3) to compare in hospital and late costs of both techniques .
Randomization protocol . Before randomization, all pa-
tients were evaluated by the primary clinical cardiologist, a
cardiac surgeon and an interventional cardiologist . Patients
were randomized in the study only when both the cardiac
surgeon and the interventional cardiologist believed that
functional revascularization of the patient could be achieved
by coronary artery bypass surgery or coronary angioplasty,
respectively . Patients were excluded from randomization
when there was agreement between the cardiac surgeon and
the interventional cardiologist on one of the two revascular-
ization modalities . This selection system allowed random
.
ization of only those patients for whom the choice of
coronary artery bypass surgery versus coronary angioplasty
was open to question. In these patients, the lesions being
considered in the functional revascularization strategy were
suitable for both procedures .
1.
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Inclusion criteria . Patients were eligible for inclusion in
the study if they had 1) severely limiting stable angina
despite maximal medical therapy; 2) rest unstable angina
refractory to maximal medical therapy; 3) no or minimal
symptoms but with a large area of myocardium at risk
identified`by exercise testing. Patients were required to have
angiographic evidence of severe coronary obstruction
0:70%) in more than one major epicardial coronary artery
and all lesions included in the revascularization strategy
were, from the angiographic point of view, amenable to both
coronary angioplasty and coronary artery bypass surgery .
ExichoW criteria . Patients were excluded from the study
If they had 1) dilated ischemic cardiomyopathy ; 2) an indi.
cation for coronary artery bypass surgery but not for coro-
nary angioplasty (patients in this category Included those
with a) severe left main trunk stenosis, b) severe three-
vessel disease and depressed ejection fraction (s35%), and
c) associated severe valvular heart disease or hypertrophic
heart disease, or both; 3) evolving acute myocardial infarc .
Lion; 4) limited life expectancy due to terminal illness ; or
5) not given consent .
Revucularlzatlo techniques. Coronary artery bypass
surgery was performed with standard surgical techniques,
under hypothermic arrest and using blood cardioplegia.
Complete revascularization was performed when possible
using reverse saphenous vein grafts and the left internal
mammary artery as conduits. The left internal mammary
artery was employed in 76 .5% of the patients .
Coronary angioplasty was performed using standard tech-
niques as previously described. Patients were pretreatea
with aspirin, 325 mglday, and a calcium channel blocker for
at least 24 It before angioplasty . A bolus of 10,000 U of
intravenous heparin was administered at the beginning of the
procedure and
, followed by a continuous infusion of heparin
to maintain a therapeutic partial thromboplastin time (70 to
80 s) for an additional 24 h. Successful angioplasty was
defhted•as again in lumen diameter .n20% and a final residual
stenosis <50%.
The strategy of revascularization with coronary angio-
pasty was carefully planned before the procedure to achieve
complete functional revascularization . The identified culprit
lesion was dilated first followed by angioplasty of the other
critical lesions during the same procedure or in a second
procedure. Only significant lesions (?-70% stenosis) with
evidence of ischemia by noninvasive testing were dilated .
Total occlusions were attempted only when there was evi-
dence of viable or hibernating myocardium, or both, in the
area supplied by the occluded vessel, Coronary angioplasty
of chronically occluded vessels (>3 months) supplying aki-
netic left ventricular segments was not attempted .
Complete anatomic revascularization after coronary an-
gioplasty was defined as no residual stenosis >50% in any
mayor epicardial coronary artery
. Complete functional revas-
ailarization after angioplasty was defined as no residual
stencils >50% in any major epicardial vessel supplying
viable myocardium
. Although the presence of a total chronic
occlusion supplying a nonviable segment of the left ventricle
represents "incomplete anatomic revascularization," it
could be present in the presence of "complete functional
revascularization" if the other arteries had <50% residual
stenosis after angioplasty .
The major in-hospital complications of both procedures :
death,
Q
wave myocardial infarction and the need for
emergency revascularization procedure (coronary angio-
plasty or coronary artery bypass surgery) were recorded .
Randomization of patients fulfilling the inclusion criteria was
performed by the coordinating center by 10 patient blocks .
Forty patients were randomized in 1988, 37 patients in 1989
and 50 patients in 1990 . Eight of the 64 patients assigned to
bypass grafting (12.5%) crossed over to angioplasty and 8
(12.6%) of the 63 patients assigned to angioplasty crossed
over to bypass grafting (p = NS) . A trained staff was
responsible for data collection of variables and clinical
follow-up of patients (using tabulated forms) . The organiza-
tion and analysis of the results of the study were conducted
by a central coordinating executive committee . The study
was monitored by a Safety and Data Monitoring Committee .
Sample calculation. To estimate follow-up ischemic
events (death, myocardial infarction and angina) related to
coronary angioplasty or coronary artery bypass surgery in
patients with multiple vessel coronary artery disease, previ-
ous published nonrandomized results were used . Estimating
a combined event-free survival at I-, 3- and 5-year follow-up
of 75% to 85% in the group with bypass grafting and 55% to
65% in the group with angioplasty ; the estimated sample was
approximately 160 patients at an alpha value of 0 .05 and a
power of 80%. Because the sample was 127 patients, the
power of this study is 70%.
Statistical analysis . Differences in baseline characteristics
and in in-hospital complications between the two groups
were determined using chi-square analysis . Event-free sur-
vival between the two groups at l-year follow-up was
compared using the Kaplan-Meier method and the log-rank
test,
Results
Baseline characteristics. Clinical. Randomization re-
sulted in balanced treatment groups . There were no differ-
ences in age, gender, history of smoking, diabetes, hyper-
cholesterolemia and previous myocardial infarction between
the two groups of patients. The incidence of unstable angina
was high in the overall cohort of patients (83%) and was
more frequent in the group with coronary artery bypass
surgery than in the group with coronary angioplasty
(89%o vs .
76%, p < 0.05) (Table 1) .
Angiographic . The two groups (angioplasty and bypass
grafting) were also well matched for arteriographic and
ventriculographic characteristics . There were no significant
differences in the number of vessels, culprit arteries and left
ventricular function between the two groups of patients
(Table l) .
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Table 1. Demographic and Angiographic Characteristics of the
Randomized Patients
Type 01
33.1
Data are expressed as mean value ± SD or number or percent of patients .
CABG = coronary artery bypass graft surgery ; LAD = left anterior descend-
ing coronary artery ; LCx = left circumflex: coronary artery ; LVEF = left
ventricular ejection fraction ; PTCA = coronary angioplasty ; RCA = right
coronary artery .
Results of coronary angioplasty. The angiographic char-
acteristics of the lesions in the coronary angioplasty group
included 3 .7% type A lesions, 83 .5% type B lesions (33 .1%
type B t and 50.4% type B2) and 12
.8% type C lesions (Fig .
2) .
The overall primary success rate of angioplasty per lesion
was 91.7% (100 of 109) : 100%a in type A lesions, 95
.6% in
type B lesions and 64 .2% in type C lesions . The success rate
was 95.7% for combined types A and B lesions
.
As part of the revascularization strategy, coronary angio-
plasty was not attempted in 44 chronic total occlusions (in
patients with a previous history of myocardial infarction)
Figure 2. Incidence of modified ACC/AHA score of 109 lesions
treated with coronary angioplasty . ACC = American College of
Cardiology; AHA = American Heart Association
.
Modified ACCIAHA/Score
Type A
3.7
(rpm 109)
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Table 2. Major In-Hospital Complications of the
Randomized Group
*No differences between groups were significant . AMI = acute myocar-
dial infarction: other abbreviations as in Table I .
supplying an area of nonviable myocardium as determined
by noninvasive testing .
In-hospital complications. There were no significant dif-
ferences in major in-hospital complications between the two
groups of patients. The in-hospital mortality rate of patients
in the coronary artery bypass surgery group was 4 .6% versus
1 .5% in the group with coronary angioplasty ; 6.2% of
patients in the bypass grafting group had a Q wave myocar-
dial infarction versus 6 .3% in the angioplasty group ; 1 .5% of
the patients in the bypass grafting group needed in-hospital
angioplasty and 1 .5% of patients in the angioplasty group
needed emergency bypass grafting (Table 2) . There were two
strokes (3 .1%) in the bypass grafting group and
I stroke
(1 .5%) in the angioplasty group .
Complete revascularization . Complete anatomic revascu-
larization was more frequently achieved in the group with
coronary artery bypass surgery than in the group with
coronary angioplasty (88% vs . 51%, p < 0 .001). However,
revascularization was functionally complete in 89 .2% of the
angioplasty group (Fig. 3) .
Patients with randomizable criteria who were not random-
ized . As described above, from the cohort of 175 patients
with criteria of randomization who were not randomized, 99
patients were treated with coronary angioplasty and 76
patients with coronary artery bypass surgery . There were no
significant differences in age. gender, history of smoking,
diabetes, elevated cholesterol level
and previous myocardial
infarction between patients treated with angioplasty or with
bypass grafting. The incidence of unstable angina was also
similar between the two groups (76.7% vs
. 72.3% for patients
Figure 3. Comparison of completeness of anatomic revasculariza-
tion with coronary angioplasty and coronary artery bypass surgery .
Completeness of functional revascularization achieved wilt
. angio-
plasty is also shown
. Abbreviations as in Figure l .
CABG
(n = 64)
PTCA
P
(n = 63) Value
Age iyr)
Men
55 ± 8
57
59 ± 2
SI
NS
NS
Women
7 12 NS
Smoking
45 39 NS
Hypertension 37 33 NS
Diabetes 7 7 NS
Hypercholesterolemia 39 35 NS
Hypeniricemia 7 7 NS
Old myocardial infarction 31 32 NS
Unstable angina 57 48
<
0 .05
LVEF (%)
62 *_ 12 59 ± 12 NS
Two vessels (%a) 53.1 57.1
NS
Three vessels (%)
Culprit artery
46 .9 42 .9
NS
LAD (%)
36
.9 37 .9 NS
RCA
(%)
33 .6
28 .7 NS
LCx (%n)
29 .5 33 .4 NS
CABG In = 64) PTCA In = 631
Death 4 .6^!r
. (3/64) 1 .5% (1/63)
AMI 6.2% (4/64)
6.3%(4163)
Emergency CABG - 1 .5% (1163)
Emergency PTCA 1 .5%(1/64) --
Stroke 3 .1% (2164) 1 .5 % (ii63i
100
80
Type B2
50.4
60
40
20
0
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Table 3. Major In-Hospital Complications of Patients With
Criteria for Randomization Who Were Not Randomized*
*No differences between groups were significant . Abbreviations as in
Tables l and 2.
treated with angioplasty and bypass grafting, respectively) .
Patients treated with bypass grafting had a higher incidence
of three-vessel coronary artery disease than did patients
treated with angioplasty (52 .7% vs . 33%, respectively).
Major in-hospital complications in this cohort of patients
with criteria for randomization who were not randomized are
shown in Table 3 . The in-hospital mortality rate was 2% for
the 99 patients treated with coronar, Angioplasty and 5 .2%
for the 76 patients treated with coronary artery bypass
surgery; the incidence of periprocedure myocardial infarc-
tion was 5% for the angioplasty group and 3 .9% for the
bypass grafting group, and the incidence of emergency
bypass grafting in patients with coronary angioplasty was
2%. There were no strokes in the angioplasty group and two
strokes (2 .6%) in the bypass grafting group . These compli-
cations are similar to those occurring in the randomized
group. Because in this cohort of patients the strategy of
angioplasty was to treat the culprit artery, complete ana-
tomic revascularization was significantly less in the angio-
plasty group than in the bypass grafting group (45 .4% vs .
90.7%. respectively).
One-year Allow-up data. At I year of follow-up, there
were two deaths in the coronary angioplasty group (3,2%)
versus none (0%) in the coronary artery bypass surgery
DAYS
group (p = NS) . One patient died suddenly 4 months after
successful angioplasty . The other patient had an anterior
myocardial infarction after unsuccessful angioplasty and
died of congestive heart failure 6 months later. Two patients
(3.2%) in the angioplasty group had a new Q wave myocar-
dial infarction versus one (1 .8%) in the bypass grafting group
(p = NS) .
Figure 4 shows the 1-year survival, freedom from myo-
cardial infarction, freedom from angina and freedom from
combined coronary cardiac events for those patients treated
with coronary angioplasty and coronary artery bypass sur-
gery. Although there were no differences in survival and
freedom from myocardial infarction between the two groups,
freedom from angina, freedom from repeat revascularization
procedures (angioplasty or bypass grafting), and freedom
from combined events were higher in the bypass graying
group than in the angioplasty group . Patients treated with
angioplasty had a greater incidence of angina and need for a
repeat revascularization procedure (angioplasty or bypass
grafting) than did patients treated with bypass grafting .
Thirty-two percent of the patients (20 of 62) in the angio-
plasty group needed a second revascularization procedur- :
(9 had repeat angioplasty and I 1 underwent bypass grafting i
versus 3.2% of the patients (2 of 61) in the bypass grafting
group (p < 0.001). However, after 6 months of follow-up
(when patients treated with angioplasty had a second revas-
cularization procedure) freedom from angina was similar in
both groups .
As seen in Figure 5, at I year of follow-up there were
nonsignificant differences in freedom from combined isch-
emic events between patients in whom coronary angioplasty
resulted in complete functional revascularization and those
in whom it resulted in cv nplete anatomic revascularization .
Ninety-six percent of the patients with complete functional
revascularization became asymptomatic after successful
coronary angioplasty .
Figure 4. Comparison of survival (upper left),
freedom from acute myocardial infarction
(AMI, upper right), freedom from angina (bot-
tom left) and freedom from combined events
(bottom right) of patients treated with coro-
nary artery bypass surgery (CABG) versus
coronary angioplasty (PTCA) .
CABG (n = 76) PICA (n = 99)
heath (9'a)
5 .2
2
AMI (9r) 3 .9
5
Emergency CABO (95) - 2
Emergency PfCA (9O) -
Stroke (96) 2 .6 0
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Figure 5. Effect of completeness of anatomic revascularization
(ACR) versus functional revascularization (FCR) and 1-year event-
free survival in patients treated with coronary angioplasty .
In-hospital and late costs. In Argentina there is a cost (all
costs in this section are in U .S. dollars) of $4,000 and $5,000
for uncomplicated and complicated coronary angioplasty,
respectively, aid of $12,000 and $15,000 for uncomplicated
and complicated coronary artery bypass surgery, respec-
tively .
Hospital costs for the 63 patients with coronary angio-
plasty including their in-hospital complications (one emer-
gency coronary artery bypass surgery) was $270,000 . Hos-
pital costs for the 64 patients with coronary artery bypass
surgery of (52 uncomplicated and 12 complicated) was
$820 '100 (p < 0.01) .
In the period of follow-up of 1 year in the coronary
angioplasty group, there were 9 repeat angioplasty proce-
dures and 11 coronary artery bypass surgery procedures
because of restenosis, adding $160,000 to the coronary
angioplasty cost . Consequently, the total cost of coronary
angioplasty (in-hospital and 1st year follow-up) was
$438,000. In contrast, in the coronary artery bypass surgery
group two patients underwent angioplasty during the 1st
year of follow-up, adding $8,000 to the bypass grafting group
cost. Therefore, the total cost of the bypass grafting group
(in-hospital and 1st year follow-up) was $828,000 (p < 0 .01).
Discussion
The present : andomized study of coronary angioplasty
versus coronary artery bypass surgery in the treatment of
patients with multivessel coronary artery disease showed no
significant differences in major in-hospital complications
(death, acute myocardial infarction and need for emergency
revascularization procedure) between patients treated with
bypass grafting or angioplasty . This study also shows that at
I year of follow-up there were no significant differences in
mortality and freedom from myocardial infarction between
the two groups of patients . However, patients treated with
bypass grafting were more frequently free of angina and
combined ischemic events than were patients treated with
angioplasty. Furthermore, although anatomic complete re-
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vascalarization was achieved more frequently in patients
treated with bypass grafting than with angioplasty, the
incidence of patients achieving complete functional revascu-
larization with angioplasty was similar to the incidence of
complete anatomic revascularization achieved with bypass
grafting . In addition in the present study in hospital cost and
cumulative cost up to 1 year of follow-up were greater for the
bypass grafting than for the angioplasty group .
Go--hospital results. The incidence of major in-hospital
complications was similar in both groups as reflected in
similar rats for in-hospital mortality, incidence of acute
myocardia infarctioa and the need for emergency revascu-
larization procedure . Similar in-hospital results were ob-
tained in the 175 patients (99 treated with coronary angio-
plasty and 76 with coronary artery bypass surgery) who met
randomization criteria but were not randomized .
Our primary PTCA success rate is similar to that reported
in other nonrandomized studies with similar patient cohorts
(12,14) . Both the higher mortality and the higher incidence of
periprocedure acute myocardial infarction in our overall
patient population are more likely to be related to patient
baseline characteristics . A high incidence of unstable angina
(83%) was present in our patients with multivessel disease .
An increased mortality and a higher incidence of periopro-
cedure myocardial infarction have been reported in patients
with unstable angina treated with both bypass grafting and
angioplasty (12,20). Furthermore, the success and complica-
tion rates of coronary angioplasty are related to the type of
angiographic lesion (21) . Our patients have a higher inci-
dence of type B and C lesions and only a 3 .7% incidence of
a type A lesion . A higher incidence (11%) of in-hospital
complications associated with angioplasty of type B or C
lesions has been reported (21). The need for emergency
surgery in our angioplasty group was similar to the incidence
previously reported in nonrandomized trials (13,16,21) .
The 4.6% in-hospital mortality rate and the 6.2% inci-
dence of myocardial infarction in the bypass grafting group
are similar to results reported in other series of patients with
unstable angina and multivessel coronary artery disease .
Perioperative mortality between 1 .8% and 8.5% and periop-
erative incidence of myocardial infarction between 1.0% and
16.7% has been reported previously in patients with unstable
angina (17,20,22,24) .
Revascularization status. Complete revascularization is
an important factor determining the long-term follow up of
patients with multivessel disease who have undergone a
revascularization procedure. Several studies have shown
that patents who have undergone complete revasculariza-
tion after coronary artery bypass surgery have improved
survival at follow-up (25,27) . Conversely, with coronary
angioplasty this seems to be less evident (16,28)
. It is well
known that in most patients with multivessel disease com-
plete revascularization is infrequently achieved with angio-
plast . Reasons for incomplete revascularization with angio-
plasty include chronic total occlusions and the strategy of
not dilating coronary lesions that are not critical
. It is well
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known that complications with angioplasty are unpredictable
and can occur with dilation of nonsignii cant lesions . Fur-
thermore, if restenosis occurs, the restenosis lesion often is
more severe than the initial one .
Coronary angioplasty has been reporird to achieve com-
plete revascularization in <50% of the patients with multiply .
vessel coronary artery disease (3,4,7,16,28) . However, in-
complete angiographic anatomic revascularization is part of
the strategy of coronary angioplasty. In our series "incom-
plete anatomic revaseularization" was the result of total
chronic occlusion in which the occluded artery was supply-
ing areas of nonviable myocardium after an old myocardial
infarction. However, in those patients "complete functional
revascularization" was frequently achieved because all the
vessels supplying viable areas had successful angioplasty .
The concept of "functional revascularization" is supported
by similar event-free survival rates early after angioplasty in
patients with complete anatomic and complete functional
revascularization. Furthermore, there were no differences
between the latter two groups in the incidence of angina at 6
months of follow-up secondary to restenosis . The advan-
tages of complete anatomic revascularization achieved with
bypass grafting over complete functional revascularization
obtained with coronary angioplasty are unknown . However,
it is possible that revascularization of all the vessels is
unnecessary when total chronic occlusions serving nonvia-
ble myocardium are present .
Late iblivw'up, Our study shows a higher event-free
survival rate (p < 0,005) in the group with coronary artery
bypass surgery than in the group with coronary angioplasty
(.83.5% vs. 63 .7%) (Fig, 4) . The difference is due only to a
higher incidence of recurrence of angina and need for repeat
revascularization procedures . Mortality and freedom from
myocardial infarction were similar in both groups . The
higher incidence rates of angina in the angioplasty group, at
1 year of follow-up, occurred during the tat 6 months and
represent restenosis after successful angioplasty . As a result
of restenosis, 32% of patients in the angioplasty group were
subjected to a repeat revascularization procedure, 55% (11
of 20) of them to bypass grafting and 45% (9 of 20) to repeat
angioplasty, A decision to perform either bypass grafting or
angioplasty as a repeat revascularization procedure was
made by the cardiologist responsible for the patient care,
Event-free survival rates after 6 months (after repeat
intervention for restenosis) were similar in both groups of
patients. Our study is in agreement with previously reported
nonrandomized studies (3,6,8,16,28,29) in patents with mul-
tivessel coronary angioplasty showing a restenosis rate of
30% to 40% requiring repeat coronary angioplasty or core
nary artery bypass surgery during follow-up . Restenosis
after angioplasty remains the main limitation of this proce-
dure in the treatment of patients with multivessel disease .
Our practice has been to recommend bypass grafting when
all lesions previously dilated develop restenosis at follow-up .
However, if restenosis occurs in only one or two vessels, we
recommend repeat angioplasty as a repeat revascularization
procedure at follow-up .
Study limitation. Our study sample is small but it is
sufficiently large to achieve our primary aim of comparing
freedom from combined coronary events at follow-up with
both forms of therapy in patients with multiple vessel disease
requiring a revascularization procedure . Our data are further
strengthened by similar results obtained in the additional 175
patients (99 treated with coronary angioplasty aad 75 with
coronary artery bypass surgery) with criteria for randomiza-
tion who were not randomized. In the present study, :a high
prevalence rate of unstable angina was present in our cohort
of patients with multivessel disease. It has been well estab-
lished that the complications of revascularization procedures
(12,16,21) are more frequent in patients with unstable an-
gina; it is possible that results would be different in a cohort
of patients with chronic stable angina . Other randomized
studies (30) in progress in the United States and in Europe
are evaluating coronary artery bypass surgery versus coro-
nary angioplasty in patients with multivessel disease in a
large cohort of patients and with a lower incidence of
unstable angina .
Conclusions. Our study found no significant differences
in in-hospital major complications between patients treated
with coronary artery bypass surgery and coronary angio-
plasty .
Although complete anatomic revascularization was more
frequently achieved in the bypass grafting than in the angio-
plasty group, complete functional revascularization was
similar in both. At 1-year follow-up, there were no differ-
ences between survival and freedom from myocardial infarc-
tion; however, patients in the bypass grafting group were
more frequently free of angina and from combined events
than were patients in the angioplasty group . In-hospital cost
and cumulative cost at 1-year of follow-up were greater for
the bypass grafting than for the angioplasty group .
We thank Jose Luis Palazzo, MD and the Anchorena Foundation for their
support in this trial.
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